Novartis
تفاصيل التقرير
ESG Index: Access to medicines
ESG Index: Access to medicines
Our approach and targets
Improving access to medicines remains one of the world’s greatest healthcare
challenges. At Novartis, we know that building trust with society depends not only on
finding new treatments but also on making them available to as many people as
possible.
Through the Novartis Access Principles, we seek to expand access to our medicines to
underserved patient populations in both developed and developing countries, while
addressing major global...
Our approach and targets
Improving access to medicines remains one of the world’s greatest healthcare
challenges. At Novartis, we know that building trust with society depends not only on
finding new treatments but also on making them available to as many people as
possible.
Through the Novartis Access Principles, we seek to expand access to our medicines to
underserved patient populations in both developed and developing countries, while
addressing major global...
نوع التقرير
تقرير استدامة شامل
اللغة
الإنجليزية
السنة
الصيغة
PDF
معايير التقرير:
GRI
ISSB
UN SDG
تقارير مشابهة
(حسب الوسوم المحددة) القطاع / الجغرافيا
نوع التقرير
|
٢٠٢٣
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
نوع التقرير
|
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
نوع التقرير
|
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.